Supernus Pharmaceuticals, Inc. (SUPN)
48.35
-1.08
(-2.18%)
USD |
NASDAQ |
May 18, 16:00
47.86
-0.49
(-1.01%)
After-Hours: 20:00
Supernus Pharmaceuticals Total Liabilities (Quarterly) : 423.92M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 176.89M |
| Johnson & Johnson | 119.71B |
| Amphastar Pharmaceuticals, Inc. | 874.77M |
| Assertio Holdings, Inc. | 135.67M |
| Eli Lilly & Co. | 85.38B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.501B |
| Shareholders Equity (Quarterly) | 1.077B |
| Debt to Equity Ratio | 0.038 |
| Current Ratio | 1.956 |
| Net Debt Paydown Yield | -0.04% |